Renishaw plc’s (LON:RSW) Sell Rating Reaffirmed at Deutsche Bank AG

Renishaw plc (LON:RSW)‘s stock had its “sell” rating reiterated by equities research analysts at Deutsche Bank AG in a research note issued to investors on Monday, August 7th. They currently have a GBX 3,180 ($41.28) price objective on the stock. Deutsche Bank AG’s price target would suggest a potential downside of 28.72% from the stock’s previous close.

A number of other research firms have also recently issued reports on RSW. Numis Securities Ltd cut Renishaw plc to a “hold” rating and set a GBX 3,700 ($48.03) price target on the stock. in a report on Wednesday, May 10th. Barclays PLC reiterated an “underweight” rating on shares of Renishaw plc in a report on Tuesday, April 25th. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of GBX 3,497.17 ($45.40).

Renishaw plc (LON:RSW) opened at 4461.00 on Monday. The firm’s 50-day moving average is GBX 4,037.30 and its 200-day moving average is GBX 3,495.09. The firm’s market capitalization is GBX 3.25 billion. Renishaw plc has a 1-year low of GBX 2,355.00 and a 1-year high of GBX 4,561.00.

ILLEGAL ACTIVITY WARNING: “Renishaw plc’s (LON:RSW) Sell Rating Reaffirmed at Deutsche Bank AG” was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at

Renishaw plc Company Profile

Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.

Analyst Recommendations for Renishaw plc (LON:RSW)

What are top analysts saying about Renishaw plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Renishaw plc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit